Alvarez's MVP Chalk Is Overpriced—And His Injury Resume Is the Reason

Yordan Alvarez sits as the overwhelming favorite in American League MVP betting—a position that makes surface-level sense given his offensive production this season. Yet the odds embed an assumption of durability that his injury history contradicts sharply. With roughly seven weeks left in the regular season, the window for something to derail his candidacy is still wide enough that the market has likely overcorrected on his inevitability.

Alvarez's resume carries legitimate MVP credentials: his power output, on-base percentage, and barrel rates rank among the league's elite, and Houston's competitive position puts him in contention-friendly context. But the voting public and betting markets are pricing him as if the next two months will unfold without disruption—a betting error when the player has undergone multiple surgeries, dealt with back issues, and missed significant stretches in four of the last five seasons. His career games-played average sits below 140 per year. Over a 162-game sample, that's a meaningful gap from full availability.

The injury risk compounds in late August and September when fatigue and wear accelerate. Contenders sometimes rest star players down the stretch, further fragmenting playing time in the months when voters are forming final impressions. Alvarez's offensive profile is strong enough that he could coast to the award even with a two-week absence, but the probability of zero meaningful injury or rest is lower than the odds currently allow. Competitors like Juan Soto, Kyle Schwarber, and emerging challengers would inherit a much clearer narrative if Alvarez's availability drops even slightly—or if another hitter enters a sustained hot streak.

From a prop angle, the value flips entirely depending on how you're positioned. If you're fading Alvarez outright at current odds, you're exploiting the market's overconfidence in his health and full participation. If you're backing a secondary candidate—someone in the 5-to-1 range who has also maintained health—you're getting cleaner odds on a voter pool that might fracture if the favorite stumbles. The MVP market is unique in that injury information can swing outcomes within weeks, not months. A late-season stint on the injured list doesn't just reduce Alvarez's counting stats; it often eliminates him from serious consideration entirely, shifting the entire leaderboard. That binary tail risk is being priced into favorites at a discount.